Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Management Strategies for Diabetic Macular Oedema

Conceição Lobo, José Cunha-Vaz
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jan 25th 2011 European Ophthalmic Review,2007:71-2 DOI: http://doi.org/10.17925/EOR.2007.00.00.71
Select a Section…
1

Article

Diabetic retinopathy remains the major cause of blindness in working-age adults in developed nations. Diabetic retinal lesions are still reversible at the initial stage of mild non-proliferative diabetic retinopathy, opening real opportunities for effective intervention. Four main alterations characterise the early stages of diabetic retinopathy:

• microaneurysms/haemorrhages;
• alteration of the blood–retinal barrier (BRB);
• capillary closure; and
• alterations in the neuronal and glial cells of the retina.


Diabetic retinopathy remains the major cause of blindness in working-age adults in developed nations. Diabetic retinal lesions are still reversible at the initial stage of mild non-proliferative diabetic retinopathy, opening real opportunities for effective intervention. Four main alterations characterise the early stages of diabetic retinopathy:

• microaneurysms/haemorrhages;
• alteration of the blood–retinal barrier (BRB);
• capillary closure; and
• alterations in the neuronal and glial cells of the retina.

These alterations may be monitored by red-dot counting on eye fundus images, and by leakage and retinal thickness measurements.1,2 A combination of these methods through multimodal macula mapping has contributed to the identification of three phenotypes2 showing different patterns of evolution:

• pattern A, including eyes with reversible and relatively little abnormal fluorescein leakage, a slow rate of microaneurysm formation and normal foveal avascular zones;
• pattern B, including eyes with persistently high leakage values and high rates of microaneurysm accumulation; and
• pattern C, including eyes with variable leakage, high rates of microaneurysm accumulation and abnormal foveal avascular zones.

2

Article Information

Received

2011-01-25T00:00:00

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup